Shire Investors Say AbbVie Can't Ax Suit Over Failed Inversion

By Jeff Zalesin · May 19, 2015, 5:45 PM EDT

A putative class of Shire PLC shareholders said Monday that AbbVie Inc. must face claims that it harmed investors by downplaying the tax incentives for the drugmakers' $55 billion merger, which...

To view the full article, register now.